Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Kenvue shareholders will receive $3.50 per share in cash and 0.14625 Kimberly-Clark shares for each Kenvue share held at closing. That amounts to $21.01 per share, based on the closing price of Kimberly-Clark shares on Friday.
Kimberly-Clark shareholders are expected to own about 54% of the combined company. Kenvue shareholders will own about 46%.
The deal is expected to close in the second half of next year. It still needs approval from shareholders of both both companies.
Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal WHEC.com.
Hence then, the article about kimberly clark buying tylenol maker kenvue in 48 7 billion deal was published today ( ) and is available on News10NBC ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal )
Also on site :